-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Maintains Hold on RxSight, Lowers Price Target to $7

Benzinga·08/10/2026 12:31:26
Listen to the news
Stifel analyst Tom Stephan maintains RxSight (NASDAQ:RXST) with a Hold and lowers the price target from $8 to $7.